# Beckman Coulter, Inc. clinical trials: 31 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 31 trials with Beckman Coulter, Inc. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Beckman Coulter, Inc.: 31 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/beckman-coulter-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 31
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 31, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 16, 2025 | NCT07217431 | Access BNP Clinical Performance Evaluation: Testing and Clinical Concordance Study | Beckman Coulter, Inc. | Observational | Completed | Heart Failure | 1,361 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07217431) |
| March 20, 2025 | NCT06885528 | Adult MDW Dual Cut-Off Accuracy Study | Beckman Coulter, Inc. | Observational | Terminated | Sepsis | 524 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06885528) |
| November 15, 2024 | NCT06691477 | A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method） | Beckman Coulter, Inc. | Observational | Completed | Heart Failure, Acute Coronary Syndromes | 1,104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06691477) |
| October 2, 2024 | NCT06624293 | Access BNP Clinical Enrollment Study | Beckman Coulter, Inc. | Observational | Completed | Heart Failure | 1,100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06624293) |
| April 23, 2024 | NCT06379061 | Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts | Beckman Coulter, Inc. | Observational | Completed | Infection, Bacterial, Infection Viral | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06379061) |
| March 4, 2024 | NCT06289868 | Access Anti-HAV and Access Anti-HAV IgM Assays EU Clinical Trial Protocol (HAV-EU-11-23) | Beckman Coulter, Inc. | Observational | Completed | HAV | 1,409 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06289868) |
| February 20, 2024 | NCT06267742 | Clinical Trial to Evaluate MDW for Early Detection of Sepsis | Beckman Coulter, Inc. | Observational | Active not recruiting | Sepsis | 2,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06267742) |
| February 14, 2024 | NCT06257628 | MACE CDS Software Master Enrollment Protocol | Beckman Coulter, Inc. | Observational | Withdrawn | Cardiac Events | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06257628) |
| April 19, 2023 | NCT05819762 | Evaluation of ClearLLab LS Screening Panel | Beckman Coulter, Inc. | Observational | Completed | Hematologic Malignancy, Hematologic Neoplasms, Hematologic Diseases | 831 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05819762) |
| July 20, 2022 | NCT05467449 | DxFLEX 10C Clinical Study | Beckman Coulter, Inc. | Observational | Completed | Hematological Malignancy | 527 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05467449) |
| March 31, 2022 | NCT05304728 | Sepsis Clinical Decision Support \[CDS\] Master Enrollment Study Protocol | Beckman Coulter, Inc. | Observational | Enrolling by invitation | Severe Sepsis, Severe Sepsis Without Septic Shock | 40,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05304728) |
| July 21, 2021 | NCT04971343 | Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol | Beckman Coulter, Inc. | Observational | Completed | HIV I Infection, HIV-2 Infection | 8,650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04971343) |
| July 21, 2021 | NCT04971330 | Access Anti-HCV Assay European Union (EU) Clinical Trial Protocol | Beckman Coulter, Inc. | Observational | Completed | HCV | 7,901 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04971330) |
| May 27, 2021 | NCT04904835 | Access HBV Assays - European Union (EU) Clinical Trial Protocol - | Beckman Coulter, Inc. | Observational | Completed | HBV | 21,210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04904835) |
| March 26, 2021 | NCT04819035 | Sepsis Post Market Clinical Utility Simple Endpoint Study - Indiana University Hospital | Beckman Coulter, Inc. | Observational | Completed | Sepsis, Adult Disease, Severe Sepsis, Emergency Department | 127 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04819035) |
| March 25, 2021 | NCT04816630 | Feasibility Study of Hematology Parameters in COVID-19 Disease | Beckman Coulter, Inc. | Observational | Completed | Covid19, Sepsis, Adults, Emergency Department | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04816630) |
| March 18, 2021 | NCT04804306 | Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC | Beckman Coulter, Inc. | Observational | Completed | Sepsis, Adult Disease, Emergency Department, Severe Sepsis | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04804306) |
| April 20, 2020 | NCT04353388 | Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University | Beckman Coulter, Inc. | Observational | Completed | Sepsis, Adult Disease, Severe Sepsis, Emergency Department | 1,139 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04353388) |
| March 3, 2020 | NCT04292431 | Leukocyte MOrphology and CORticosteroids Response in SEPtic Patients (MOCORSEP) | Beckman Coulter, Inc. | Observational | Completed | Sepsis, Septic Shock, Sepsis Syndrome, Infection | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04292431) |
| March 2, 2020 | NCT04291417 | Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&W | Beckman Coulter, Inc. | Observational | Completed | Sepsis, Adult Disease, Emergency Department, Severe Sepsis | 1,700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04291417) |
| November 20, 2019 | NCT04169815 | Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection | Beckman Coulter, Inc. | Observational | Completed | Heart Failure | 2,370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04169815) |
| July 17, 2018 | NCT03588325 | Evaluation of MDW for Early Detection of Sepsis, Clinical Validity | Beckman Coulter, Inc. | Observational | Completed | Severe Infection, Sepsis, Severe Sepsis | 947 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03588325) |
| January 29, 2018 | NCT03413644 | Evaluation of ClearLLab Leukemia and Lymphoma Panels | Beckman Coulter, Inc. | Observational | Completed | Leukemia-Lymphoma | 482 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03413644) |
| October 18, 2017 | NCT03313635 | Evaluation of Prealbumin Levels in Men With Low-T | Beckman Coulter, Inc. | Observational | Completed | Testosterone Deficiency | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03313635) |
| August 8, 2017 | NCT03243266 | DxH520 Pediatric Reference Interval Verification | Beckman Coulter, Inc. | Observational | Completed | Healthy Subjects | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03243266) |

## By phase

| Phase | Trials |
| --- | --- |
| Observational | 31 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 24 |
| Terminated | 4 |
| Withdrawn | 1 |
| Active not recruiting | 1 |
| Enrolling by invitation | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Sepsis | 11 |
| Emergencies | 6 |
| Disease | 5 |
| Heart Failure | 4 |
| Infections | 3 |
| Hepatitis B | 2 |
| Hematologic Neoplasms | 2 |
| Hematologic Diseases | 2 |
| COVID-19 | 1 |
| Shock, Septic | 1 |
| Systemic Inflammatory Response Syndrome | 1 |
| Sleep Apnea, Obstructive | 1 |
| Cardiovascular Diseases | 1 |
| Bacterial Infections | 1 |
| Virus Diseases | 1 |
| Acute Coronary Syndrome | 1 |
| Hepatitis | 1 |
| Hepatitis C | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Packaging companies in the United States](https://specstream.ai/data/businesses/packaging-companies/united-states)
- [Burger restaurants in the United States](https://specstream.ai/data/businesses/burger-restaurants/united-states)
- [Occupational safety services in the United States](https://specstream.ai/data/businesses/occupational-safety-services/united-states)
- [Bistros in the United States](https://specstream.ai/data/businesses/bistros/united-states)
- [Mortgage lenders in the United States](https://specstream.ai/data/businesses/mortgage-lenders/united-states)
- [Banks and credit unions in the United States](https://specstream.ai/data/businesses/banks-and-credit-unions/united-states)
